Dilution of Share Value from the Exercise of Stock Acquisition Rights
First written in FY2022. 1 of 7 entries say "Softened", first in FY2023. Latest entry: FY2024-Q3.
The whole theme swung hardest in 2017: 37 of 68 companies on the "Worse" side.
5 other companies' latest entry also says "Other".
- FY2024-Q3Increase in shares through the exercise of stock acquisition rightsAnnual report
「Between 1 January 2024 and 31 January 2024, shares issued increased by 130,400 as a result of the exercise of stock acquisition rights.」
Exercise of stock acquisition rights progressed after the quarter-end, increasing shares issued by 130,400. - FY2024-Q1New grants of share acquisition rightsAnnual report
「11th Series Stock Acquisition Rights」
Under the 11th series of stock acquisition rights, rights equivalent to 30,600 common shares were granted to 130 employees of our company and 11 employees of subsidiaries. The exercise period runs from 1 June 2026 to 31 May 2030. - FY2023SoftenedAnnual report
「As of the end of the fiscal year ended March 2023, the number of potentially dilutive shares was 174,700, equivalent to 3.3% of the total 5,327,800 shares issued.」
The potentially dilutive share ratio fell from 9.9% in the previous fiscal year to 3.3%, reducing the quantitative scale of potential dilution. However, the possibility that the stock acquisition rights may be exercised remains. - FY2023-Q3Continued exercise of stock acquisition rightsAnnual report
「1 October 2022–31 December 2022 40,000 5,165,400 2,500 632,426 2,500 596,458 (Note) The increase resulted from the exercise of stock options.」
During the third quarter, the exercise of stock acquisition rights increased shares issued by 40,000, and capital stock and capital surplus each increased by ¥2.5 million. - FY2023-Q2Continued exercise of stock acquisition rightsAnnual report
「Between 1 July 2022 and 30 September 2022, shares issued increased by 76,000 as a result of the exercise of stock acquisition rights.」
Stock acquisition rights were exercised during the second quarter, increasing shares issued by 76,000. - FY2023-Q1New grants and exercise of stock acquisition rightsAnnual report
「Class, details and number of shares underlying the stock acquisition rights (shares)*: Common shares 27,900」
While 27,900 common shares were granted under the 10th series of stock acquisition rights, shares issued increased by 68,400 during the first quarter as a result of the exercise of existing stock acquisition rights. Both new grants and exercises affecting potential dilution were disclosed. - FY2022First statedAnnual report
「As of the end of the fiscal year ended March 2022, the number of potentially dilutive shares was 494,400, equivalent to 9.9% of the total 4,981,000 shares issued.」
The risk of dilution of share value through the exercise of stock options was quantified at 494,400 potentially dilutive shares, or 9.9% of total shares issued.